(EMMUSC) UBS(Lux)Fund Solutions – - Ratings and Ratios
Exchange: SW • Country: Switzerland • Currency: USD • Type: Etf • ISIN: LU0950674175 • Global Emerging Markets Equity
EMMUSC: Stocks, Bonds, Emerging Markets, Equities
UBS(Lux) Fund Solutions – MSCI Emerging Markets UCITS ETF (USD) A-acc (SW:EMMUSC) is a Luxembourg-domiciled exchange-traded fund designed to provide exposure to emerging markets equities. The fund tracks the MSCI Emerging Markets Index, a widely recognized benchmark for emerging market performance. With an AUM of $2.978 billion, it offers a diversified portfolio of stocks across various emerging economies.
The ETF employs a replication strategy, aiming to closely track the performance of its underlying index. This approach minimizes tracking error while ensuring cost-efficiency. The fund is structured as a UCITS-compliant ETF, which provides investor protections and regulatory oversight under the Undertakings for the Collective Investment in Transferable Securities framework.
As an emerging markets ETF, it is inherently exposed to higher volatility and risks associated with developing economies. However, this also presents the potential for higher returns over the long term. The fund’s diversification across multiple countries and sectors helps mitigate some of the regional and industry-specific risks. Investors should consider their risk tolerance and investment horizon before allocating to this fund.
The fund’s A-acc share class is denominated in USD, making it accessible to global investors seeking exposure to emerging markets without currency conversion. The ETF is listed on the Swiss exchange (SW) under the ticker EMMUSC, providing liquidity and ease of access for investors. UBS Asset Management, the issuer, brings extensive experience in ETF management, further enhancing the fund’s operational reliability and tracking accuracy.
Additional Sources for EMMUSC ETF
EMMUSC ETF Overview
Market Cap in USD | 3,144m |
Category | Global Emerging Markets Equity |
TER | 0.20% |
IPO / Inception | 2018-06-18 |
EMMUSC ETF Ratings
Growth 5y | 28.5% |
Fundamental | - |
Dividend | 0.0% |
Rel. Strength Industry | 2.69 |
Analysts | - |
Fair Price Momentum | 10.69 USD |
Fair Price DCF | - |
EMMUSC Dividends
No Dividends PaidEMMUSC Growth Ratios
Growth Correlation 3m | 59.2% |
Growth Correlation 12m | 69.5% |
Growth Correlation 5y | -6.6% |
CAGR 5y | 8.80% |
CAGR/Max DD 5y | 0.22 |
Sharpe Ratio 12m | 0.56 |
Alpha | 1.66 |
Beta | 0.66 |
Volatility | 21.16% |
Current Volume | 200.5k |
Average Volume 20d | 315.3k |
As of March 14, 2025, the stock is trading at USD 11.77 with a total of 200,454 shares traded.
Over the past week, the price has changed by -1.58%, over one month by -0.81%, over three months by +1.05% and over the past year by +8.45%.
Neither. Based on ValueRay Analyses, UBS(Lux)Fund Solutions – is currently (March 2025) neither a good nor a bad stock to buy. It has a ValueRay Growth Rating of 28.54 and therefor a technical neutral rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of EMMUSC as of March 2025 is 10.69. This means that EMMUSC is currently overvalued and has a potential downside of -9.18%.
UBS(Lux)Fund Solutions – has no consensus analysts rating.
According to ValueRays Forecast Model, EMMUSC UBS(Lux)Fund Solutions – will be worth about 11.9 in March 2026. The stock is currently trading at 11.77. This means that the stock has a potential upside of +0.76%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 11.9 | 0.8% |